CoreCivic Q1 Revenue Up 25.8% to $614.7M, EPS Soars 74%
CoreCivic delivered first-quarter revenue of $614.7 million, up 25.8% year-over-year, with net income rising 51% to $37.9 million and adjusted EPS climbing 73.9% to $0.40. The company activated four previously idle facilities, repurchased 2.3 million shares for $44.7 million and acquired Clinical Solutions Pharmacy to diversify cash flows.
1. Strong First Quarter Financials
CoreCivic reported Q1 revenue of $614.7 million, a 25.8% increase year-over-year, driven by higher federal and state populations. Net income rose 51% to $37.9 million, while diluted EPS grew 65.2% to $0.38 and adjusted EPS surged 73.9% to $0.40, reflecting operational gains and tax credits.
2. Facility Activations and Population Growth
The activation of four previously idle facilities—including the 2,400-bed Dilley Immigration Processing Center and the 2,560-bed California City Detention Facility—boosted occupancy to 79.6%. New contract awards at West Tennessee and Diamondback Correctional facilities further supported higher per-diem revenues and improved operating margins in the Safety and Community segments.
3. Acquisition of Clinical Solutions Pharmacy
Subsequent to quarter-end, CoreCivic acquired Clinical Solutions Pharmacy, a leading provider of mail order pharmacy services for correctional facilities. This strategic move diversifies revenue streams into a growing healthcare market and complements existing facility operations by adding predictable cash flows.
4. Balance Sheet Strength and Liquidity
The company maintained leverage at a 2.8x net debt to adjusted EBITDA ratio and secured a $100 million incremental term loan after quarter-end to bolster liquidity. CoreCivic repurchased 2.3 million shares for $44.7 million and continues to explore debt capital markets and potential asset sales to enhance financial flexibility.